
CapyBio designs and engineers AI-driven cell-based products for regenerative medicine and research. It uses proprietary AI and computational biology to map gene regulatory networks and guide stem-cell differentiation. The company provides engineered cell lines for biomedical research and partners to develop therapeutic cell-based solutions. CapyBio operates in the biotech space focusing on regenerative medicine with collaborations across pharma and research institutions. Its technology enables scalable cell engineering workflows and targeted differentiation across cardiac and liver lineages.

CapyBio designs and engineers AI-driven cell-based products for regenerative medicine and research. It uses proprietary AI and computational biology to map gene regulatory networks and guide stem-cell differentiation. The company provides engineered cell lines for biomedical research and partners to develop therapeutic cell-based solutions. CapyBio operates in the biotech space focusing on regenerative medicine with collaborations across pharma and research institutions. Its technology enables scalable cell engineering workflows and targeted differentiation across cardiac and liver lineages.